Sensitivity to ALA-PDT of cell lines with different nitric oxide production and resistance to NO cytotoxicity

Journal of Photochemistry and Photobiology B: Biology

Volumn 80, Issue 3, 2005, Pages 195-202

  Di Venosa, Gabriela ^a   Perotti, Christian ^a   Fukuda, Haydée ^a   Batlle, Alcira ^a   Casas, Adriana ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b NONE   (Argentina)

Author keywords

5 Aminolevulinic acid; ALA PDT; Nitric oxide; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; ARGININE; HYDROLYASE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM;

ADENOCARCINOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOSYNTHESIS; BLOOD FLOW; CANCER THERAPY; CARCINOMA CELL; CELL PROTECTION; CONTROLLED STUDY; CROSS RESISTANCE; CYTOTOXICITY; DRUG MECHANISM; DRUG RESPONSE; ENZYME INHIBITION; HYPOTHESIS; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ADENOCARCINOMA; AMINOLEVULINIC ACID; ANIMALS; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; L CELLS (CELL LINE); MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED BALB C; NITRIC OXIDE; NITRIC OXIDE DONORS; PHOTOCHEMOTHERAPY; PORPHYRINS;

MURINAE;

EID: 23844473380     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2005.05.001     Document Type: Article

References (33)

1. T. Dougherty Photodynamic therapy (PDT) of malignant tumors Crit. Rev. Oncol. Hematol. 2 1984 83-116
2. J. Kennedy R. Pottier G. Pross Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experience J. Photochem. Photobiol. B 6 1990 143-148
3. H. Fukuda A. Casas F. Chueke S. Paredes A. Batlle Photodynamic action of endogenously synthesized porphyrins from aminolevulinic acid, using a new model for assaying the effectiveness of tumoral cell killing Int. J. Biochem. 25 1993 1395-1398
4. S. Moncada R. Palmer E. Higgs Nitric oxide: Physiology, phatology and pharmacology Pharmacol. Rev. 43 1991 109-142
5. P. Kim R. Zamora P. Petrosko T. Billiar The regulatory role of nitric oxide in apoptosis Int. Immunopharmacol. 1 2001 1421-1441
6. J. Stamler Redox signaling: Nitrosilation and related target interactions of nitric oxide Cell 78 1994 931-936
7. C. Nathan Q. Xie Nitric oxide synthases: Roles, tolls and controls Cell 78 1994 915-918
8. M. Korbelik The role of nitric oxide in the response of solid tumors to photodynamic therapy Photochem. Photobiol. 65 1997 S55-S56
9. B. Henderson T. Sitnik-Busch L. Vaughan Potentiation of photodynamic therapy antitumor activity in mice by nitric oxide synthase inhibition is fluence rate dependent Photochem. Photobiol. 70 1999 64-71
10. M. Korbelik C. Parkins H. Shibuya I. Cecic M. Stratford D. Chaplin Nitric oxide production by tumour tissue: Impact on the response to photodynamic therapy Br. J. Cancer 82 2000 1835-1843
11. M. Niziolek W. Korytowski A. Girotti Nitric oxide inhibition of free radical-mediated lipid peroxidation in photodynamically treated membranes and cells Free Rad. Biol. Med. 24 2003 997-1005
12. W. Gomes R. Almeida P. Carvalho C. Duarte Nitric oxide modulates tumor cell death induced by photodynamic therapy through a cGMP-dependent mechanism Photochem. Photobiol. 76 2002 423-430
13. S. Gupta N. Ahmad H. Mukhtar Involvement of nitric oxide during phthalocyanine (Pc4) photodynamic therapy-mediated apoptosis Cancer Res. 58 1998 1785-1788
14. T. Dalbasti S. Cagli E. Kiline N. Oktar M. Ozsoz Online electrochemical monitoring of nitric oxide during photodynamic therapy Nitric Oxide 7 2002 301-305
15. A. Eijan L. Davel H. Rueda G. Rozenberg E. Lustig M. Jasnis Differential nitric oxide release and sensitivity to injury in different murine mammary tumour cell lines Int. J Mo. Med. 2 1998 625-630
16. S. Galli L. Davel M. Jasnis M. Sales E. Lustig A. Eijan Selección de una línea de células tumorales resistente a la citotoxicidad por óxido nítrico Medicina de Buenos Aires 59 5/2 1999 63
17. S. Galli L. Colombo S. Vanzuli M. Daroqui M. Vidal A. Jasnis E. Lustig A. Eiján Characterization of a fibroblastoid mammary carcinoma cell line (LM2) originated from a mouse adenocarcinoma Int. J. Oncol. 17 2000 1259-1265
18. A. Urtreger V. Ladeda L. Puricelli A. Rivelli M. Vidal E. Lustig E. Bal de Kier Joffe Modulation of fibronectin expression and proteolytic activity associated with the invasive and metastatic phenotype in two new murine mammary tumor cell lines Int. J. Oncol. 11 1997 489-496
19. D. Granger J. Hidds J. Perfect D. Durack Metabolic fate of L-arginine inhalation to microbiostatic capability of murine macrophages J. Clin. Invest. 85 1990 264-273
20. F. Denizot R. Lang Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability J. Immunol. Methods 89 1986 271-277
21. N. Bustos A. Stella E. Wider A. Batlle Studies on erythrocytic aminolevulinate dehydratase. I. Its purification and possible therapeutic applications Int. J. Biochem. 12 1980 745-750
22. A. Batlle E. Wider A. Stella A simple method for measuring erythrocyte porphobilinogenase, and its use in the diagnosis of acute intermittent porphyria Int. J. Biochem. 1978 871-876
23. J. Bates M. Baker R. Guerra D. Harrison Nitric oxide generation from nitroprusside by vascular tissue Biochem. Pharmacol. 42 1991 S157-S165
24. I. Ioannidis M. Batz P. Thomas H.-G. Korth R. Sustmann H. de Groot Enhanced release of nitric oxide causes increased cytotoxicity of S-nitroso-N-acetyl-dl-penicillamine and sodium nitroprusside under hypoxic conditions Biochem. J. 318 1996 789-795
25. C. Fraga J. Onuki F. Lucesoli E. Bechara P. Di Mascio 5-Aminolevulinic acid mediates the in vivo and in vitro formation of 8-hydoxy-2′-deoxyguanosine in DNA Carcinogenesis 15 1994 2241-2244
26. D. Wolff A. Naddelman A. Lubeskie D. Saks Inhibition of nitric oxide synthase isoforms by porphyrins Arch. Biochem. Biophys. 333 1996 27-34
27. S. Correa García A. Casas C. Perotti A. Batlle M. Bermudez Moretti Mechanistic studies on 5-aminolevulinic acid uptake and efflux in a mammary adenocarcinoma cell line Br. J. Cancer 89 2003 173-177
28. D. Fukumura F. Yuan M. Endo K. Jain Role of nitric oxide in tumor microcirculation. Blood flow, vascular permeability, and leukocyte-endothelial interactions Am. Pathol. 150 1997 713-725
29. G-nitro-l-arginine Cancer Res. 54 1994 6458-6463
30. J. Beckman Oxidative damage and tryrosine nitration from peroxynitrite Chem. Res. Toxicol. 9 1996 836-844
31. D. Wink J. Mitchell Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide Free Radic. Biol. Med. 25 1998 434-456
32. H. Rubbo M. Radi M. Trujillo R. Telleri B. Kalyanaraman S. Barnes M. Kirk B. Freeman Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives J. Biol. Chem. 269 1994 26066-26075
33. L. Rossig B. Fichtlscherer K. Breitschopf J. Haendeler A. Zeiher A. Mulsch G. Dimmeler Nitric oxide inhibits caspase-3 by S-nitrosation in vivo J. Biol. Chem. 274 1999 6823-6826